Biogen cov khoom lag luam poob 3.7% tom qab tshaj tawm cov nyiaj tau los, hais tias nws tau nqa $ 1 lab hauv kev muag tshuaj Alzheimer hauv lub quarter thib plaub.

Ib qho dhau los ntawm tsab ntawv ceeb toom no muaj qhov kev pom zoo tsis raug thiab tus lej nyiaj tau los. Nws tau raug kho lawm. Shares ntawm Biogen Inc. BIIB, -1.92% tau nqis 3.7% hauv kev lag luam ua ntej hnub Thursday tom qab lub compa ...

Biogen cov khoom lag luam poob qis tom qab Asmeskas tawm tswv yim txwv kev nkag mus rau nws cov tshuaj Alzheimer's kab mob

Biogen Inc.'s BIIB, -8.92% Tshuag poob 9.3% hauv kev ua lag luam ua ntej hnub Wednesday, hnub tom qab cov tswj hwm tau thov txwv kev nkag mus rau cov chav kawm ntawm Alzheimer's cov tshuaj uas suav nrog lub tuam txhab th...

Biogen's Alzheimer's Drug Aduhelm muaj lwm qhov kev txhaj tshuaj ntawm kev ua tiav

Daim duab los ntawm Elias Stein Text size Biogen's Alzheimer's disease therapy, Aduhelm, tau ua rau poob siab rau lub tuam txhab txij li nws tau pom zoo los ntawm Food and Drug Administration lub caij nplooj ntoos hlav dhau los, nrog rau thaum ntxov ...

Vim li cas Biogen's Alzheimer's tshuaj Aduhelm thiaj li muaj teeb meem

Lub US Food and Drug Administration tau pom zoo los ntawm Biogen's Alzheimer's tshuaj Aduhelm thaum Lub Rau Hli tau tshaj tawm tias yog qhov kev yeej keeb kwm hauv kev tawm tsam tus kab mob uas tua ntau txhiab o ...